Barings’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-35,400
| Closed | -$346K | – | 1040 |
|
|
2017
Q1 | $346K | Buy |
35,400
+17,700
| +100% | +$173K | ﹤0.01% | 973 |
|
|
2016
Q4 | $191K | Hold |
17,700
| – | – | ﹤0.01% | 849 |
|
|
2016
Q3 | $181K | Hold |
17,700
| – | – | ﹤0.01% | 769 |
|
|
2016
Q2 | $231K | Hold |
17,700
| – | – | 0.01% | 835 |
|
|
2016
Q1 | $195K | Hold |
17,700
| – | – | 0.01% | 893 |
|
|
2015
Q4 | $163K | Hold |
17,700
| – | – | ﹤0.01% | 884 |
|
|
2015
Q3 | $123K | Hold |
17,700
| – | – | ﹤0.01% | 868 |
|
|
2015
Q2 | $174K | Hold |
17,700
| – | – | 0.01% | 927 |
|
|
2015
Q1 | $157K | Hold |
17,700
| – | – | ﹤0.01% | 929 |
|
|
2014
Q4 | $155K | Hold |
17,700
| – | – | ﹤0.01% | 904 |
|
|
2014
Q3 | $122K | Hold |
17,700
| – | – | ﹤0.01% | 924 |
|
|
2014
Q2 | $93K | Hold |
17,700
| – | – | ﹤0.01% | 951 |
|
|
2014
Q1 | $81K | Hold |
17,700
| – | – | ﹤0.01% | 904 |
|
|
2013
Q4 | $89K | Hold |
17,700
| – | – | ﹤0.01% | 902 |
|
|
2013
Q3 | $90K | Hold |
17,700
| – | – | ﹤0.01% | 915 |
|
|
2013
Q2 | $88K | Buy |
+17,700
| New | +$88K | ﹤0.01% | 868 |
|